AlphaYouMS
Insider selling
Matthew Shields sold $322K of Teva Pharmaceutical Industries Ltd (TEVA) stock
Matthew Shields, EVP, Global Operations of Teva Pharmaceutical Industries Ltd (TEVA), sold 9,989 shares of TEVA stock worth $322K, per an SEC Form 4 filed Jun 22, 2026.
It was an open-market sale.
The trade happened on Jun 18, 2026, 4 days before it was made public.
TEVA has moved +25.5% since the trade date, from $31.48 to $39.52 (Sep 22, 2026 close).
- Traded
- Jun 18, 2026
- Disclosed
- Jun 22, 2026
- Filing delay
- 4 days
- Price since
- +25.5%
- Role
- EVP, Global Operations
- Source
- SEC Form 4
More TEVA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.